[Effect of chemoimmunotherapy on the sensitivity of T-lymphocytes to theophylline in lymphoma].
The state of the T-cellular immunity system was studied in mice with experimental lymphoma during the treatment with cyclophosphamide and active specific immunotherapy with ConA-modified syngeneic tumor cells. The advantages of the combined method of treatment and the high informative value of the test of E-rosette-formation sensitivity to theophylline in the evaluation of the therapeutic effect have been shown.
Bratus'
G G
GG
Darchuk
G F
GF
D000818:Animals; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D016219:Immunotherapy, Adoptive / Q000379:methods*; D066298:In Vitro Techniques; D008223:Lymphoma / Q000276:immunology / Q000628:therapy*; D051379:Mice; D008808:Mice, Inbred CBA; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy*; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D013806:Theophylline / Q000494:pharmacology*
D003520:Cyclophosphamide; D013806:Theophylline
Vliianie khimioimmunoterapii na chuvstvitel'nost' T-limfotsitov k teofillinu pri limfome.